| NCT Number | NCT07636590 |
| Lead Sponsor | Claris Biotherapeutics, Inc. |
| Conditions | Limbal Stem Cell Deficiency |
| Enrollment | 500 participants |
| Start Date | 2026-05-22 |
| Primary Completion | 2028-03 (estimated) |
| Study Completion | 2028-03 (estimated) |
| Updated on ClinicalTrials.gov | 2026-08-06 |